Included under terms of UK Non-commercial Government License.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Westwood M, Ramaekers B, Lang S, et al. ImmunoCAP® ISAC and Microtest for multiplex allergen testing in people with difficult to manage allergic disease: a systematic review and cost analysis. Southampton (UK): NIHR Journals Library; 2016 Sep. (Health Technology Assessment, No. 20.67.)
ImmunoCAP® ISAC and Microtest for multiplex allergen testing in people with difficult to manage allergic disease: a systematic review and cost analysis.
Show detailsThe authors acknowledge the clinical advice and expert opinion provided by Dr Isabel Skypala, Consultant Allergy Dietitian & Clinical Lead for Food Allergy at Royal Brompton & Harefield NHS Foundation Trust; Dr Paul Turner, Clinical Senior Lecturer, Paediatric Allergy & Immunology, Imperial College London and St Mary’s Hospital, London; Ms Roisin Fitzsimons, Allergy Nurse Consultant, Guys and St Thomas’ NHS Foundation Trust; Dr Anthony Rowbottom, Consultant Immunologist, Lancashire Teaching Hospital NHS Trust; and Dr Michael Ardern-Jones, Senior Lecturer, University of Southampton, and Consultant Dermatologist, University Hospital Southampton NHS Foundation trust. We would also like to thank the lay members of the NICE Diagnostics Advisory Committee and Assessment Sub-group for providing input on the patients’ perspective at key stages of the assessment process.
This is a systematic review and therefore all extracted data are included in the report. Further information can be obtained from the corresponding author.
Contributions of authors
Marie Westwood and Shona Lang planned and performed the systematic review and interpretation of evidence.
Bram Ramaekers planned and performed the cost-effectiveness analyses and interpreted results.
Nigel Armstrong contributed to planning and interpretation of cost-effectiveness analyses, acquisition of input data and conducted model peer review.
Caro Noake and Shelley de Kock devised and performed the literature searches and provided information support to the project.
Manuela Joore, Johan Severens and Jos Kleijnen provided senior advice and support to the systematic review and cost-effectiveness analyses, respectively.
All parties were involved in drafting and/or commenting on the report.
Data sharing statement
This is a systematic review; therefore, there are no additional data to share. Further information can be obtained from the corresponding author.
Disclaimers
This report presents independent research funded by the National Institute for Health Research (NIHR). The views and opinions expressed by authors in this publication are those of the authors and do not necessarily reflect those of the NHS, the NIHR, NETSCC, the HTA programme or the Department of Health. If there are verbatim quotations included in this publication the views and opinions expressed by the interviewees are those of the interviewees and do not necessarily reflect those of the authors, those of the NHS, the NIHR, NETSCC, the HTA programme or the Department of Health.
- Acknowledgements - ImmunoCAP® ISAC and Microtest for multiplex allergen testing ...Acknowledgements - ImmunoCAP® ISAC and Microtest for multiplex allergen testing in people with difficult to manage allergic disease: a systematic review and cost analysis
- Homo sapiens chromosome 19 open reading frame 81 (C19orf81), mRNAHomo sapiens chromosome 19 open reading frame 81 (C19orf81), mRNAgi|1653961064|ref|NM_001195076.2|Nucleotide
- ubiquitin carboxyl-terminal hydrolase CYLD isoform 1 [Homo sapiens]ubiquitin carboxyl-terminal hydrolase CYLD isoform 1 [Homo sapiens]gi|1819229346|ref|NP_001365672.1|Protein
Your browsing activity is empty.
Activity recording is turned off.
See more...